394 related articles for article (PubMed ID: 22067139)
1. Parkinson's disease and dementia: a longitudinal study (DEMPARK).
Balzer-Geldsetzer M; Costa AS; Kronenbürger M; Schulz JB; Röske S; Spottke A; Wüllner U; Klockgether T; Storch A; Schneider C; Riedel O; Wittchen HU; Seifried C; Hilker R; Schmidt N; Witt K; Deuschl G; Mollenhauer B; Trenkwalder C; Liepelt-Scarfone I; Gräber-Sultan S; Berg D; Gasser T; Kalbe E; Bodden M; Oertel WH; Dodel R
Neuroepidemiology; 2011; 37(3-4):168-76. PubMed ID: 22067139
[TBL] [Abstract][Full Text] [Related]
2. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.
Galtier I; Nieto A; Lorenzo JN; Barroso J
J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176
[TBL] [Abstract][Full Text] [Related]
3. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
[TBL] [Abstract][Full Text] [Related]
4. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.
Hobson P; Meara J
Int J Geriatr Psychiatry; 2015 Oct; 30(10):1048-55. PubMed ID: 25676160
[TBL] [Abstract][Full Text] [Related]
5. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
[TBL] [Abstract][Full Text] [Related]
6. PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies.
Gomperts SN; Marquie M; Locascio JJ; Bayer S; Johnson KA; Growdon JH
Neurodegener Dis; 2016; 16(1-2):118-24. PubMed ID: 26655867
[TBL] [Abstract][Full Text] [Related]
7. White matter hyperintensities in cognitive impairment with Lewy body disease: a multicentre study.
Gan J; Shi Z; Liu S; Li X; Liu Y; Zhu H; Shen L; Zhang G; Lu H; Gang B; Chen Z; Ji Y
Eur J Neurol; 2023 Dec; 30(12):3711-3721. PubMed ID: 37500565
[TBL] [Abstract][Full Text] [Related]
8. Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease.
Lee JE; Cho KH; Song SK; Kim HJ; Lee HS; Sohn YH; Lee PH
J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):7-16. PubMed ID: 23828835
[TBL] [Abstract][Full Text] [Related]
9. Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study.
Kalbe E; Rehberg SP; Heber I; Kronenbuerger M; Schulz JB; Storch A; Linse K; Schneider C; Gräber S; Liepelt-Scarfone I; Berg D; Dams J; Balzer-Geldsetzer M; Hilker R; Oberschmidt C; Witt K; Schmidt N; Mollenhauer B; Trenkwalder C; Spottke A; Roeske S; Wittchen HU; Riedel O; Dodel R
J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1099-105. PubMed ID: 27401782
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study.
Pedersen KF; Larsen JP; Tysnes OB; Alves G
JAMA Neurol; 2013 May; 70(5):580-6. PubMed ID: 23529397
[TBL] [Abstract][Full Text] [Related]
11. Natural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study.
Pedersen KF; Larsen JP; Tysnes OB; Alves G
Neurology; 2017 Feb; 88(8):767-774. PubMed ID: 28108638
[TBL] [Abstract][Full Text] [Related]
12. Spectroscopic changes associated with mild cognitive impairment and dementia in Parkinson's disease.
Pagonabarraga J; Gómez-Ansón B; Rotger R; Llebaria G; García-Sánchez C; Pascual-Sedano B; Gironell A; Delfino M; Ruscalleda J; Kulisevsky J
Dement Geriatr Cogn Disord; 2012; 34(5-6):312-8. PubMed ID: 23208306
[TBL] [Abstract][Full Text] [Related]
13. Association of arterial stiffness with cognition in patients with Lewy body disorder.
Ryu DW; Kim JS; Lee JE; Park JW; Oh YS; An JY; Lee KS
Neurol Sci; 2017 Jul; 38(7):1307-1313. PubMed ID: 28474150
[TBL] [Abstract][Full Text] [Related]
14. Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease.
van der Zee S; Vermeiren Y; Fransen E; Van Dam D; Aerts T; Gerritsen MJ; Spikman JM; van Laar T; De Deyn PP
J Parkinsons Dis; 2018; 8(1):71-84. PubMed ID: 29480224
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal study of normal cognition in Parkinson disease.
Pigott K; Rick J; Xie SX; Hurtig H; Chen-Plotkin A; Duda JE; Morley JF; Chahine LM; Dahodwala N; Akhtar RS; Siderowf A; Trojanowski JQ; Weintraub D
Neurology; 2015 Oct; 85(15):1276-82. PubMed ID: 26362285
[TBL] [Abstract][Full Text] [Related]
16. α-synuclein genetic variability: A biomarker for dementia in Parkinson disease.
Guella I; Evans DM; Szu-Tu C; Nosova E; Bortnick SF; ; Goldman JG; Dalrymple-Alford JC; Geurtsen GJ; Litvan I; Ross OA; Middleton LT; Parkkinen L; Farrer MJ
Ann Neurol; 2016 Jun; 79(6):991-9. PubMed ID: 27091628
[TBL] [Abstract][Full Text] [Related]
17. Structural and functional imaging study in dementia with Lewy bodies and Parkinson's disease dementia.
Borroni B; Premi E; Formenti A; Turrone R; Alberici A; Cottini E; Rizzetti C; Gasparotti R; Padovani A
Parkinsonism Relat Disord; 2015 Sep; 21(9):1049-55. PubMed ID: 26109553
[TBL] [Abstract][Full Text] [Related]
18. The mild cognitive impairment stage of dementia with Lewy bodies and Parkinson disease: a comparison of cognitive profiles.
Yoon JH; Lee JE; Yong SW; Moon SY; Lee PH
Alzheimer Dis Assoc Disord; 2014; 28(2):151-5. PubMed ID: 24126215
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal assessment of the pattern of cognitive decline in non-demented patients with advanced Parkinson's disease.
Gasca-Salas C; Estanga A; Clavero P; Aguilar-Palacio I; González-Redondo R; Obeso JA; Rodríguez-Oroz MC
J Parkinsons Dis; 2014; 4(4):677-86. PubMed ID: 25208730
[TBL] [Abstract][Full Text] [Related]
20. New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes.
Fereshtehnejad SM; Romenets SR; Anang JB; Latreille V; Gagnon JF; Postuma RB
JAMA Neurol; 2015 Aug; 72(8):863-73. PubMed ID: 26076039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
